These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 3624490

  • 1. 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.
    Abecassis M, Falk JA, Makowka L, Dindzans VJ, Falk RE, Levy GA.
    J Clin Invest; 1987 Sep; 80(3):881-9. PubMed ID: 3624490
    [Abstract] [Full Text] [Related]

  • 2. The immune response to mouse hepatitis virus: expression of monocyte procoagulant activity and plasminogen activator during infection in vivo.
    Dindzans VJ, MacPhee PJ, Fung LS, Leibowitz JL, Levy GA.
    J Immunol; 1985 Dec; 135(6):4189-97. PubMed ID: 2999239
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The comparative effects of cyclosporin A and 16,16 dimethyl prostaglandin E2 on the allogeneic induction of monocyte/macrophage procoagulant activity and the cytokines macrophage procoagulant inducing factor and interleukin-2.
    Chung SW, Kim PC, Koh IH, Fung LS, Cole EH, Cohen Z, Levy GA.
    Immunology; 1991 Dec; 74(4):670-6. PubMed ID: 1783425
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin E2 prevents fulminant hepatitis and the induction of procoagulant activity in susceptible animals.
    Abecassis M, Falk J, Dindzans V, Lopatin W, Makowka L, Levy G, Falk R.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1103-5. PubMed ID: 2856269
    [No Abstract] [Full Text] [Related]

  • 6. Prostaglandin E2 (PGE2) alters the pathogenesis of MHV-3 infection in susceptible BALB/cJ mice.
    Abecassis M, Falk J, Dindzans V, Lopatin W, Makowka L, Levy G, Falk R.
    Adv Exp Med Biol; 1987 Feb; 218():465-6. PubMed ID: 2829560
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cellular and metabolic requirements for induction of macrophage procoagulant activity by murine hepatitis virus strain 3 in vitro.
    Chung S, Sinclair S, Leibowitz J, Skamene E, Fung LS, Levy G.
    J Immunol; 1991 Jan 01; 146(1):271-8. PubMed ID: 1701794
    [Abstract] [Full Text] [Related]

  • 9. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
    Fingerote RJ, Cruz BM, Gorczynski RM, Fung LS, Hubbell HR, Suhadolnik RJ, Levy GA.
    J Gen Virol; 1995 Feb 01; 76 ( Pt 2)():373-80. PubMed ID: 7844557
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of alterations in early signal transduction events on the induction of procoagulant activity by murine hepatitis virus strain 3 in vitro.
    Chung SW, Rotstein OD, Downey GP, Levy GA.
    J Gen Virol; 1995 May 01; 76 ( Pt 5)():1181-7. PubMed ID: 7730802
    [Abstract] [Full Text] [Related]

  • 13. Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication.
    Pope M, Rotstein O, Cole E, Sinclair S, Parr R, Cruz B, Fingerote R, Chung S, Gorczynski R, Fung L.
    J Virol; 1995 Sep 01; 69(9):5252-60. PubMed ID: 7636967
    [Abstract] [Full Text] [Related]

  • 14. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response.
    Ning Q, Brown D, Parodo J, Cattral M, Gorczynski R, Cole E, Fung L, Ding JW, Liu MF, Rotstein O, Phillips MJ, Levy G.
    J Immunol; 1998 Apr 01; 160(7):3487-93. PubMed ID: 9531310
    [Abstract] [Full Text] [Related]

  • 15. [KCTD9, a novel potassium channel related gene, was highly expressed in hepatic NK cells and T cells of fulminant hepatitis mice induced by MHV-3].
    Zhou YY, Zou Y, Chen T, Wang HW, Han MF, Pi B, Yan WM, Xi D, Huang JQ, Luo XP, Ning Q.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov 01; 19(11):833-7. PubMed ID: 22433305
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection.
    Li C, Fung LS, Chung S, Crow A, Myers-Mason N, Phillips MJ, Leibowitz JL, Cole E, Ottaway CA, Levy G.
    J Exp Med; 1992 Sep 01; 176(3):689-97. PubMed ID: 1324969
    [Abstract] [Full Text] [Related]

  • 17. Pretreatment of donor stimulator cells by 16,16 dimethyl prostaglandin E2 influences the recipient immune response.
    Chung SW, Gould B, Zhang R, Hu Y, Levy GA, Gorczynski RM.
    Surgery; 1998 Feb 01; 123(2):171-80. PubMed ID: 9481403
    [Abstract] [Full Text] [Related]

  • 18. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B.
    Zhu CL, Yan WM, Zhu F, Zhu YF, Xi D, Tian DY, Levy G, Luo XP, Ning Q.
    World J Gastroenterol; 2005 Nov 28; 11(44):6936-40. PubMed ID: 16437596
    [Abstract] [Full Text] [Related]

  • 19. Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3.
    Yang C, Chen Y, Guo G, Li H, Cao D, Xu H, Guo S, Fei L, Yan W, Ning Q, Zheng L, Wu Y.
    Gut; 2013 Aug 28; 62(8):1204-13. PubMed ID: 22637698
    [Abstract] [Full Text] [Related]

  • 20. In vitro and long-term in vivo immune dysfunction after infection of BALB/c mice with mouse hepatitis virus strain A59.
    Cray C, Mateo MO, Altman NH.
    Lab Anim Sci; 1993 Apr 28; 43(2):169-74. PubMed ID: 8100597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.